Brain tumours and COVID‑19

Brain tumours and COVID‑19

HPP co-authored a lay summary of findings from the International Brain Tumour Alliance and Society for Neuro-Oncology survey on how COVID-19 has affected brain tumour patients and carers around the world.

Radioligand therapy

Radioligand therapy

Radioligand therapy is an innovative approach to treating certain types of cancer by delivering radiation to specifically targeted cancer cells, with a minimal effect on healthy cells.

Genetic testing for BRCA mutations

Genetic testing for BRCA mutations

Genetic mutations in the BRCA1 and BRCA2 genes are associated with a significant risk of developing breast cancer, but many people who may carry these mutations cannot access genetic testing.

Radiotherapy

Radiotherapy

As the incidence of cancer increases, healthcare systems must find effective and sustainable ways to care for all cancer patients – and radiotherapy is a key part of this.